Attend our live webinar.

Join us as we engage in a multi-disciplinary discussion around practice changing approaches to somatic and germline testing.

We will cover new data shared at the 2023 ASCO Annual Meeting on incidental germline findings, potential benefits to tumor/normal matched testing and the various approaches to somatic and germline sequencing. We will also discuss testing behaviors for NSCLC patients and the most recent findings from the PADA-1 Trial and how it may affect approaches to monitoring resistance mechanisms through liquid biopsy.

Register today!